Susan L. Greenspan, MD; Diane L. Schneider, MD; Michael R. McClung, MD; Paul D. Miller, MD; Thomas J. Schnitzer, MD, PhD; Randi Bonin, BS; Mary Elizabeth Smith, BS; Paul DeLucca, PhD; Glenn J. Gormley, MD, PhD; Mary E. Melton, MD
Greenspan SL, Schneider DL, McClung MR, Miller PD, Schnitzer TJ, Bonin R, et al. Alendronate Improves Bone Mineral Density in Elderly Women with Osteoporosis Residing in Long-Term Care Facilities: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med. 2002;136:742-746. doi: 10.7326/0003-4819-136-10-200205210-00009
Download citation file:
Published: Ann Intern Med. 2002;136(10):742-746.
Many elderly female residents of long-term care facilities have osteoporosis and could benefit from intervention to increase bone density.
To examine the efficacy and safety of alendronate for treatment of osteoporosis in elderly female residents of long-term care facilities.
Multicenter, randomized, double-blind, placebo-controlled 2-year study.
25 long-term care facilities.
327 elderly women with osteoporosis.
Patients were randomly assigned to receive alendronate, 10 mg/d, or placebo. All patients also received vitamin D, 400 IU/d, and some patients received supplemental calcium (total intake, approximately 1500 mg/d).
Bone mineral density (BMD) of the spine and hip and biochemical markers of bone turnover.
Alendronate produced significantly greater increases in BMD than did placebo (24-month differences: spine, 4.4% [95% CI, 3.3% to 5.5%]; femoral neck, 3.4% [CI, 2.3% to 4.4%]). Alendronate produced greater decreases from baseline in biochemical markers of bone turnover than did placebo (P < 0.001).
Alendronate increased BMD at both the spine and hip in elderly female residents of long-term care facilities.
For a list of investigators and investigative sites, see the Appendix.
Learn more about subscription options.
Register Now for a free account.
Endocrine and Metabolism, Geriatric Medicine, Metabolic Bone Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only